These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24665436)

  • 1. Aberrant p16INK4A methylation: Relation to viral related chronic liver disease and hepatocellular carcinoma.
    El-Mougy FA; Youssef MM; Omran DA; Sharaf SA; El-Sayed HH; Rabie WA; Mohamed EA; Elghobary HA
    South Asian J Cancer; 2014 Jan; 3(1):1-4. PubMed ID: 24665436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of aberrant p16INK4A methylation in sera of patients with liver cirrhosis and hepatocellular carcinoma.
    Chu HJ; Heo J; Seo SB; Kim GH; Kang DH; Song GA; Cho M; Yang US
    J Korean Med Sci; 2004 Feb; 19(1):83-6. PubMed ID: 14966347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma.
    Li X; Hui AM; Sun L; Hasegawa K; Torzilli G; Minagawa M; Takayama T; Makuuchi M
    Clin Cancer Res; 2004 Nov; 10(22):7484-9. PubMed ID: 15569978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma.
    Wang Y; Cheng J; Xu C; Liu S; Jiang S; Xu Q; Chen X; Zhuang H; Lu F
    Liver Int; 2012 Mar; 32(3):420-8. PubMed ID: 22192146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients.
    Wong IH; Zhang J; Lai PB; Lau WY; Lo YM
    Clin Cancer Res; 2003 Mar; 9(3):1047-52. PubMed ID: 12631605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma.
    Fukai K; Yokosuka O; Imazeki F; Tada M; Mikata R; Miyazaki M; Ochiai T; Saisho H
    Liver Int; 2005 Dec; 25(6):1209-16. PubMed ID: 16343074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16INK4A gene alterations are not a prognostic indicator for survival in patients with hepatocellular carcinoma undergoing curative hepatectomy.
    Anzola M; Cuevas N; Lopez-Martinez M; Martinez de Pancorbo M; Burgos JJ
    J Gastroenterol Hepatol; 2004 Apr; 19(4):397-405. PubMed ID: 15012776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
    Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
    BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of
    Nomeir H; Elsheredy H; Nomeir A; Mostafa NR; El-Hamshary S
    Clin Exp Hepatol; 2022 Sep; 8(3):243-252. PubMed ID: 36685264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.
    Yang B; Guo M; Herman JG; Clark DP
    Am J Pathol; 2003 Sep; 163(3):1101-7. PubMed ID: 12937151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
    Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B.
    Tian MM; Fan YC; Zhao J; Gao S; Zhao ZH; Chen LY; Wang K
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):171-180. PubMed ID: 28189396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of tumour suppressor genes
    El-Bendary M; Nour D; Arafa M; Neamatallah M
    Br J Biomed Sci; 2020 Jan; 77(1):35-40. PubMed ID: 31790342
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylation status of the T-cadherin gene promotor in peripheral blood mononuclear cells is associated with HBV-related hepatocellular carcinoma progression.
    Yuan XD; Wang JW; Fang Y; Qian Y; Gao S; Fan YC; Wang K
    Pathol Res Pract; 2020 May; 216(5):152914. PubMed ID: 32147273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
    Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of promoter region of SPINT2/HAI-2 gene: an epigenetic mechanism in hepatitis C virus-induced hepatocarcinogenesis.
    Ramadan RA; Zaki MA; Awad AM; El-Ghalid LA
    Genet Test Mol Biomarkers; 2015 Jul; 19(7):399-404. PubMed ID: 26030814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of aberrant p16INK4A methylation in sera of patients with HCV-related liver diseases: An Egyptian study.
    Ahmed R; Salama H; Fouad A; Sabry D; AbdAlah el-S; Kamal M
    Med Sci Monit; 2010 Sep; 16(9):CR410-5. PubMed ID: 20802412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.
    Lee S; Lee HJ; Kim JH; Lee HS; Jang JJ; Kang GH
    Am J Pathol; 2003 Oct; 163(4):1371-8. PubMed ID: 14507645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis.
    Jain S; Xie L; Boldbaatar B; Lin SY; Hamilton JP; Meltzer SJ; Chen SH; Hu CT; Block TM; Song W; Su YH
    Hepatol Res; 2015 Nov; 45(11):1110-23. PubMed ID: 25382672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.